with EtOAc. Combined organics layers were washed with brine
and dried over anhydrous MgSO4. After removal of the solvent,
the residue was purified by column chromatography (eluant:
EtOAc). Product 7 was obtained as a white solid (0.30 g, 1.1 mmol,
92%). Mp: 145-146 °C. IR (neat): 3404, 3339, 3308, 3053, 2977,
2930, 1703, 1693, 1682, 1537, 1531, 1519, 1514, 1504, 1455, 1393,
1367, 1337, 1251, 1170 cm-1. 1H NMR (CDCl3, 300 MHz): δ )
1.44 (s, 9H), 1.76 (br s, 2H), 3.39 (ddd, J ) 6.5, 7.0 and 13.0 Hz,
1H), 3.57 (ddd, J ) 5.5, 6.5 and 13.0 Hz, 1H), 4.41 (dd, J ) 5.5
and 7.0 Hz, 1H), 4.90 (br s, 1H), 7.12 (ddd, J ) 1.0, 7.5 and 7.5
Hz, 1H), 7.13 (s, 1H), 7.20 (ddd, J ) 1.0, 7.5 and 7.5 Hz, 1H),
7.37 (d, J ) 8.0 Hz, 1H), 7.71 (d, J ) 8.0 Hz, 1H), 8.30 (bs, 1H).
13C NMR (CDCl3, 75.5 MHz): δ ) 28.4, 47.5, 48.7, 79.3, 111.3,
118.6, 119.3, 119.6, 121.0, 122.3, 125.9, 136.6, 156.2. LRMS (DCI,
NH3 + isobutane): m/z ) 276 [(M + H)+]. Anal. calcd for
C15H21N3O2: C, 65.43; H, 7.69; N, 15.26. Found: C, 65.22; H,
7.69; N, 15.19.
112.8, 113.3, 115.8, 117.1, 119.7, 120.3, 122.9, 123.0, 123.8, 124.1,
125.2, 126.7, 127.3, 138.6, 138.9, 139.4, 164.4, 180.3. LRMS
(ESI): m/z ) 329 [(M + H)+]. HRMS (ESI) calcd for C20H17N4O:
329.1402. Found: 329.1396 [(M + H)+].
Topsentin A (1a). IBX (0.17 mmol, 47 mg) was added to a
solution of the topsentin D 2a (50 mg, 0.15 mmol) in 0.6 mL of
DMSO. The resulting mixture was stirred at rt during 15 h and
monitored by TLC until completion. It was then quenched by
addition of a saturated aqueous solution of Na2S2O3 (0.38 mL) and
an equal volume of EtOAc. The mixture was treated by a saturated
aqueous solution of NaHCO3. Aqueous layer was then extracted
three times by EtOAc. Combined organic layers were successively
washed with an aqueous saturated solution of NaHCO3 and brine
and then dried over anhydrous MgSO4. After the removal of the
solvent, the residue was purified by column chromatography on
silica gel (eluent: EtOAc/pentane, 1:1). Topsentin A 1a was
obtained as a yellow solid (45 mg, 0.14 mmol). Yield: 91%. Mp:
140 °C (dec). IR (neat): 3392, 2927, 1693, 1589, 1518, 1454, 1428,
1,2-Diamino-1-(indol-3′-yl)ethane Dihydrochloride (8a). A
cold solution of hydrochloric acid was prepared at 0 °C by adding
4.69 mL (5.2 g, 66.5 mmol) of freshly distilled acetyl chloride to
15 mL of dry methanol. The solution was stirred for 15 min at 0
°C. A solution of protected diamine 7 (1.31 g, 4.75 mmol) in 20
mL of methanol was then added into the acidic solution at 0 °C.
The resulting mixture was stirred for an additional 1 h. Methanol
was then slowly evaporated under vacuum, without heating. The
indolic 1,2-diamine salt 8a was obtained as a brown solid (1.28 g,
4.75 mmol). Yield: 100%. Mp: 170 °C (decomposition). IR
(KBr): 3350, 2953, 2672, 1588, 1484, 1459, 1434, 1339, 1099,
1260, 1240, 1111, 852, 749 cm-1 1H NMR (CD3COCD3, 500
.
MHz): Isomer a: δ ) 7.12-7.24 (m, 2H), 7.24-7.29 (m, 2H,),
7.47 (d, J ) 8.0 Hz), 7.54-7.60 (m, 1H), 7.72 (s, 1H), 7.85 (d, J
) 2.0 Hz, 1H), 8.23 (d, J ) 8.0 Hz, 1H), 8.48-8.56 (m, 1H), 9.65
(d, J ) 3.0 Hz, 1H), 10.38 (s, 1H), 11.16 (s, 1H), 12.07 (s, 1H).
Isomer b: δ ) 7.12-7.24 (m, 2H), 7.24-7.29 (m, 2H), 7.52 (d, J
) 8.0 Hz, 1H), 7.54-7.60 (m, 1H), 7.63 (s, 1H), 7.97 (d, J ) 8.0
Hz, 1H), 8.08 (d, J ) 2.5 Hz, 1H), 8.50-8.56 (m, 1H), 9.42 (d, J
1
) 2.5 Hz, 1H), 10.63 (s, 1H), 11.10 (s, 1H), 12.14 (s, 1H). H
NMR (CD3COCD3 + TFA-d + D2O, 500 MHz): δ ) 7.22 (t, J )
7.0 and 8.0 Hz, 1H), 7.25 (t, J ) 7.0 and 8.0 Hz, 1H), 7.28-7.34
(m, 2H), 7.57 (d, J ) 8.0 Hz, 1H), 7.58-7.63 (m, 1H), 7.97 (d, J
) 8.0 Hz, 1H), 8.01 (s, 1H), 8.16 (s, 1H), 8.34-8.38 (m, 1H),
8.90 (s, 1H). DEPT 13C NMR (CD3COCD3, 75.5 MHz): Isomers
a and b: δ ) 106.6, 111.9, 112.3, 112.70, 112.75, 112.78, 115.0,
115.3, 115.4, 120.3, 120.4, 121.0, 121.2, 122.4, 122.7, 122.8, 123.0,
123.0, 123.2, 123.8, 123.9, 124.3, 126.0, 126.4, 127.1, 128.1, 131.0,
137.3, 137.4, 137.6, 137.8, 137.9, 138.1, 140.2, 146.6, 177.1. DEPT
13C NMR (CD3COCD3, TFA-d, D2O, 75.5 MHz): δ ) 103.1,
113.1, 113.5, 114.9, 116.4, 119.7, 121.6, 122.5, 123.6, 123.9, 125.2,
125.4, 126.3, 127.0, 132.3, 137.6, 138.0, 138.3, 141.6, 171.9. LRMS
(ESI): m/z ) 327 [(M + H)+]. HRMS (ESI) calcd for C20H15N4O:
327.1246. Found: 327.1243 [(M + H)+].
1
1012 cm-1. H NMR (CD3OD, 300 MHz): δ ) 3.65-3.85 (m,
2H), 5.09 (dd, J ) 6.3 and 8.7 Hz, 1H), 7.18 (dt, J ) 1.3 and 7.0
Hz, 1H), 7.24 (dt, J ) 1.3 and 7.0 Hz, 1H), 7.45-7.51 (m, 1H),
7.69 (s, 1H), 7.77-7.83 (m, 1H). 13C NMR (CD3OD, 75.5 MHz):
δ ) 42.4, 47.1, 107.0, 113.1, 119.0, 121.3, 123.8, 126.7, 126.7,
138.3. LRMS (ESI): m/z ) 176 for C10H14N3 [(M + H)+], 159
for C10H11N2 [(M - NH2)+]. HRMS (ESI): Calcd for C10H14N3:
176.1182. Found: 176.1184 [(M + H)+]. Calcd for C10H11N2:
159.0917. Found: 159.0917 [(M - NH2)+].
Indol-3′-yl-[5′′-(indol-3′’-yl)-4,5-dihydroimidazol-2-yl]ke-
tone (topsentin D) (2a). To a stirred solution of indolic diamine
dihydrochloride 8a (50 mg, 0.20 mmol) and thioimidate iodide 4a
(83 mg, 0.20 mmol) in distilled methanol (1 mL) was added
Amberlyst A21 (200 mg). The resulting mixture was stirred for 60
h at rt. Methanol was then removed under vacuum. To the residue
were added water and ethyl acetate. The aqueous layer was extracted
three times with EtOAc. The combined organic layers were then
washed with brine and dried over anhydrous MgSO4. After removal
of the solvent, the residue was purified by column chromatography
on silica gel (eluent: EtOAc). The R-ketoimidazoline 2a (topsentin
D) was obtained as a white solid (48 mg, 0.15 mmol). Yield: 72%.
IR (KBr): 2919, 2851, 1705, 1617, 1582, 1435, 1421, 1374, 1239,
1128 cm-1. 1H NMR (CD3OD, 300 MHz): δ ) 3.98 (dd, J ) 8.6
and 12 Hz, 1H), 4.31 (t, J ) 12 Hz, 1H), 5.56 (dd, J ) 8.6 and 12
Hz, 1H), 7.04 (dt, J ) 1.0 and 7.9 Hz, 1H), 7.14 (dt, J ) 1 and 7.2
Hz, 1H), 7.25-7.31 (m, 2H), 7.31 (s, 1H), 7.40 (d, J ) 8.2 Hz,
1H), 7.46-7.52 (m, 1H), 7.63 (d, J ) 7.9 Hz, 1H), 8.27-8.33 (m,
1H), 8.47 (s, 1H). 13C NMR (CD3OD, 75.5 MHz): δ ) 56.6, 59.1,
Acknowledgment. We thank the “Association de la Re-
cherche contre le Cancer” (ARC) for financial support. We are
grateful to ACI no. 02L0525: “Nouvelles approches the´rapeu-
tiques du cancer” for financial support. This work was supported
by a grant from the “Ministe`re de la Jeunesse, de l’Education
Nationale et de la Recherche” to X.G.
Supporting Information Available: Experimental procedures
and characterization data for compounds 1d, 1e, 2b, 2c, 4a, 4b,
1
4c, 11a, 11b, 11c, and H and 13C or 13C DEPT NMR spectra for
compounds 1a, 1d, 1e, 2a, 2b, 2c, 4a, 4b, 4c, and 8a This material
JO070286R
J. Org. Chem, Vol. 72, No. 10, 2007 3975